NEW DELHI — The price of commonly used diabetes drug empagliflozin has been slashed by almost one-tenth, with the entry of its generic versions in the market. Developed by German pharma giant Boehringer Ingelheim (BI) empagliflozin, it is sold under the name Jardiance. It is an oral medication that helps control blood sugar in patients […]
